Placeholder

South Africa: Wealth Disparity versus Pharma Opportunity

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

South Africa has been ranked by the World Bank as an upper-middle income country and is the largest economy in Africa. Yet, South Africa has a huge divide between the haves and have nots. Around 8 million people, 16% of the population, are covered by health insurance, with the vast majority using the public health system. According to Espicom, the deep division between public and private healthcare leaves the majority of the population without…

Sidebars:
South Africa at a Glance
Top Five Diseases Under Research in South Africa (2008-2012)
Clinical Trial Activity in South Africa
Top 20 Pharmaceutical Companies in South Africa

FEEDBACK